该类药物包括林可霉素及其半合成衍生物克林霉素两个品种。
作用机制林可霉素类主要作用于细菌核糖体的50S亚基,通过抑制肽链延长干扰细菌蛋白质合成,属于生长期抑菌剂。其抗菌谱与红霉素相似但较窄,主要包括:
细菌对林可霉素与克林霉素之间存在完全交叉耐药性,而与红霉素间则有部分交叉耐药性。
临床应用这类药物主要用于治疗由厌氧菌和革兰阳性球菌引起的感染,如肺炎、心内膜炎、蜂窝织炎、丹毒及泌尿系统感染等。特别适用于治疗因厌氧菌引起的各种感染以及金黄色葡萄球菌性骨髓炎的首选治疗药。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
盐酸林可霉素(一水物) | lincomycin hydrochloride hydrate | 7179-49-9 | C18H34N2O6S*ClH*2H2O |
|
盐酸林可霉素 | lincomycin hydrochloride | 859-18-7 | C18H34N2O6S*ClH |
|
盐酸克林霉素 | clindamycin hydrochloride | 21462-39-5 | C18H33ClN2O5S*ClH |
|
棕榈氯林可霉素盐酸盐 | clindamycin palmitate hydrochloride | 25507-04-4 | C34H63ClN2O6S*ClH |
|
林可霉素 | lincomycin | 17017-22-0 | C18H34N2O6S |
|
林可霉素 | lincomycin | 154-21-2 | C18H34N2O6S |
|
克林霉素磷酸酯 | clindamycin phosphate | 24729-96-2 | C18H34ClN2O8PS |
|
克林霉素 | clindamycin | 18323-44-9 | C18H33ClN2O5S |
|
—— | [6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate | 24729-96-2 | C18H34ClN2O8PS |
|
—— | Cleocin | 21462-39-5 | C18H34Cl2N2O5S |
|
—— | (2S,4R)-N-[(1S,2S)-2-Hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride | 859-18-7 | C18H35ClN2O6S |
|
—— | (2S,4R)-N-[2-chloro-1-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride | 21462-39-5 | C18H34Cl2N2O5S |
|
—— | (2S,4R)-N-[2-hydroxy-1-[(3R,4S,5S)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride | 859-18-7 | C18H35ClN2O6S |
|
—— | [(2S,3S,4R,5S,6S)-6-[(1R)-2-chloro-1-[[(2R,4S)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate | 24729-96-2 | C18H34ClN2O8PS |
|
—— | Cleocin HCL Monohydrate | 21462-39-5 | C18H34Cl2N2O5S |
|
—— | [(4S,5R)-6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate | 24729-96-2 | C18H34ClN2O8PS |
|
—— | Pharmakon1600-01505470 | 25507-04-4 | C34H64Cl2N2O6S |
|
—— | [(2R,3R,4S,5R)-6-[2-chloro-1-[[(2S)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochloride | 25507-04-4 | C34H64Cl2N2O6S |
|
—— | (2S,4R)-N-[2-hydroxy-1-[(3R,4R,5S)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride | 859-18-7 | C18H35ClN2O6S |
|
—— | (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride | 859-18-7 | C18H35ClN2O6S |
|
—— | [(2S,3S,4R,5S,6S)-6-[(1R,2R)-2-chloro-1-[[(2R,4S)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate | 24729-96-2 | C18H34ClN2O8PS |
|
—— | (4R)-N-[(1S,2S)-2-chloro-1-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride | 21462-39-5 | C18H34Cl2N2O5S |
|
—— | N-Demethyllincomycin | 2256-16-8 | C17H32N2O6S |
|
—— | Lincocin | 859-18-7 | C18H35ClN2O6S |
|
—— | lincomycin | 154-21-2 | C18H34N2O6S |
|
—— | lincomycin hydrochloride | 859-18-7 | C18H34N2O6S*ClH |
|
—— | Clindamycin-2-palmitat-hydrochlorid | 25507-04-4 | C34H63ClN2O6S*ClH |
|
—— | (2S,4R)-N-{2-chloro-1-[(2R,3R,4S,5R,6R)-3,4-dihydroxy-6-(methylsulfanyl)-5-(phosphonooxy)oxan-2-yl]propyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid | 24729-96-2 | C18H34ClN2O8PS |
|
—— | Clindamycin-2-phosphat | 24729-96-2 | C18H34ClN2O8PS |
|
—— | [6-[2-Chloro-1-[(1-methyl-4-propylpyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate | 24729-96-2 | C18H34ClN2O8PS |
|
—— | (2S,4R)-N-((1R,2R)-2-Hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-4-propylpyrrolidine-2-carboxamide | 2256-16-8 | C17H32N2O6S |
|